Compounds > niacinamide

niacinamide and guanine

niacinamide has been researched along with guanine in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (42.86)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (7.14)	29.6817
2010's	7 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, RR; Nielsen, HR; Wolf, H	1
Dean, JA	1
Wessman, G; Wessman, GE	2
Chu, BC; Lawley, PD	1
Huang, SS; Pontzer, NJ; Shaikh, B	1
Hanna, N	1
Bernard, S; Chiu, M; Davies, JM; Dees, EC; Dhruva, NS; Hayes, DN; Hilbun, LR; Ivanova, A; Keller, K; Kim, WY; Socinski, MA; Stinchcombe, TE; Walko, CM	1
Bareford, MD; Burow, ME; Cruickshanks, N; Dent, P; Eulitt, P; Fisher, PB; Grant, S; Hamed, HA; Hubbard, N; Moran, RG; Nephew, KP; Park, MA; Tang, Y; Tye, G; Yacoub, A	1
Bareford, MD; Burow, ME; Cruickshanks, N; Dent, P; Fisher, PB; Grant, S; Hamed, HA; Moran, RG; Nephew, KP; Tang, Y	1
Allegood, J; Bareford, MD; Cruickshanks, N; Dent, P; Grant, S; Hamed, HA; Ogretmen, B; Park, MA; Poklepovic, A; Spiegel, S	1
Chen, J; Chen, L; Jiang, Y; Li, C; Li, Y; Ma, Y	1
Barrington, S; Cane, P; Dunn, JT; Lal, R; Landau, D; Lang-Lazdunski, L; McLennan, B; Papa, S; Popat, S; Prevost, AT; Shah, R; Spicer, J; Viney, Z	1
D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P	1

Trials

3 trial(s) available for niacinamide and guanine

Article	Year
Second-line treatment of non-small cell lung cancer: big targets, small progress; small targets, big progress? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Docetaxel; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Niacinamide; Pemetrexed; Phenylurea Compounds; Piperidines; Probability; Prognosis; Pyridines; Quinazolines; Randomized Controlled Trials as Topic; Risk Assessment; Sorafenib; Survival Analysis; Taxoids; Treatment Outcome	2006
A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 71, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Niacinamide; Pemetrexed; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome	2011
Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Niacinamide; Pemetrexed; Phenylurea Compounds; Platinum; Pleural Neoplasms; Prognosis; Protein Kinase Inhibitors; Salvage Therapy; Sorafenib; Survival Rate	2013

Other Studies

11 other study(ies) available for niacinamide and guanine

Article	Year
Effect of tryptophan and nicotinamide loads on urinary excretion of RNA metabolites by bladder cancer patients. Journal of the National Cancer Institute, 1977, Volume: 59, Issue:3 Topics: Aminoisobutyric Acids; Guanine; Humans; Male; Niacinamide; Pseudouridine; RNA, Neoplasm; Tryptophan; Uric Acid; Urinary Bladder Neoplasms	1977
Use of nuclear magnetic resonance in determining molecular structure of urinary constituents of low molecular weight. Clinical chemistry, 1968, Volume: 14, Issue:4 Topics: Adenine; Aniline Compounds; Creatinine; Guanine; Hypoxanthines; Magnetic Resonance Spectroscopy; Niacinamide; Phenacetin; Uracil; Uridine; Urine	1968
Chemically defined media for Pasteurella multocida and Pasteurella ureae, and a comparison of their thiamine requirements with those of Pasteurella haemolytica. Canadian journal of microbiology, 1970, Volume: 16, Issue:8 Topics: Adenine; Amino Acids; Bacteriological Techniques; Chromatography, Paper; Citrates; Culture Media; Densitometry; Glucose; Guanine; Niacinamide; Pantothenic Acid; Pasteurella; Species Specificity; Sucrose; Thiamine; Uracil	1970
Requirements for growth of Pasteurella ureae in a chemically defined medium. Canadian journal of microbiology, 1972, Volume: 18, Issue:1 Topics: Adenine; Amino Acids; Carbohydrate Metabolism; Culture Media; Guanine; Hypoxanthines; Niacinamide; Pantothenic Acid; Pasteurella; Uracil; Xanthines	1972
Increased urinary excretion of pyrimidine and nicotinamide derivatives in rats treated with methyl methanesulphonate. Chemico-biological interactions, 1974, Volume: 8, Issue:2 Topics: Animals; Carbon Radioisotopes; Chromatography, Gel; Chromatography, Ion Exchange; Deoxycytidine; Dose-Response Relationship, Drug; Female; Guanine; Hypoxanthines; Mesylates; Niacinamide; Pyrimidines; Radiation; Rats; Spectrophotometry, Ultraviolet; Thymidine; Time Factors	1974
Urinary excretion of methylated purines and 1-methyl-nicotinamide following administration of methylating carcinogens. Chemico-biological interactions, 1980, Volume: 30, Issue:2 Topics: 1,2-Dimethylhydrazine; Adenine; Alkylating Agents; Animals; Carcinogens; Dimethylhydrazines; Dimethylnitrosamine; Guanine; Male; Methyl Methanesulfonate; Methylation; Methylnitronitrosoguanidine; Niacinamide; Rats	1980
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer research, 2011, Jul-15, Volume: 71, Issue:14 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Benzenesulfonates; Cell Line, Tumor; Drug Synergism; Female; Glutamates; Guanine; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Niacinamide; Pemetrexed; Phenylurea Compounds; Pyridines; Sorafenib; Tissue Distribution	2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Autophagy, 2011, Volume: 7, Issue:10 Topics: Animals; Antineoplastic Agents; Autophagy; Benzenesulfonates; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Liver Neoplasms; Mice; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Niacinamide; Pemetrexed; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Sorafenib	2011
Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer biology & therapy, 2012, Volume: 13, Issue:9 Topics: Antineoplastic Agents; Autophagy; Benzenesulfonates; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Endosomes; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Gene Knockdown Techniques; Glutamates; Guanine; Humans; MAP Kinase Signaling System; Niacinamide; Pemetrexed; Phenylurea Compounds; Protein Phosphatase 2; Pyridines; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Sorafenib; src-Family Kinases	2012
The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell lines. Clinical laboratory, 2012, Volume: 58, Issue:5-6 Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; ErbB Receptors; Glutamates; Guanine; Humans; Lung Neoplasms; MAP Kinase Signaling System; Niacinamide; Pemetrexed; Phenylurea Compounds; Protein-Tyrosine Kinases; Pyridines; Sorafenib	2012
Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma? World journal of gastroenterology, 2013, Volume: 19, Issue:14 Topics: Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Time Factors; Treatment Outcome	2013